← Evidence map

ArticleOncology letters2025

Comparison of the effects of crizotinib as monotherapy and as combination therapy with butyric acid on different breast cancer cells.

Mehmet R Topçul et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

2 papers cite it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39530008